Production (Stage)
Connect Biopharma Holdings Limited
CNTB
$0.9799
$0.02993.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -29.00% | -20.79% | -20.79% | -15.93% | -14.55% |
| Total Receivables | -- | 199.43% | 199.43% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -44.11% | -44.11% | -14.00% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -1.85% | -1.85% | -- | -- |
| Total Current Assets | -- | -20.88% | -20.88% | -15.81% | -- |
|
|
|||||
| Total Current Assets | -- | -20.88% | -20.88% | -15.81% | -- |
| Net Property, Plant & Equipment | -- | -10.54% | -10.54% | -11.16% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -14.52% | -14.52% | -11.63% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 37.50% | 37.50% | -86.94% | -- |
| Total Assets | -- | -20.48% | -20.48% | -16.01% | -- |
|
|
|||||
| Total Accounts Payable | -- | -84.52% | -84.52% | -50.33% | -- |
| Total Accrued Expenses | -- | -19.62% | -19.62% | 60.12% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -45.96% | -45.96% | -6.91% | -- |
| Total Finance Division Other Current Liabilities | -- | -96.92% | -96.92% | -55.54% | -- |
| Total Other Current Liabilities | -- | -96.92% | -96.92% | -55.54% | -- |
| Total Current Liabilities | -- | -66.54% | -66.54% | -35.30% | -- |
|
|
|||||
| Total Current Liabilities | -- | -66.54% | -66.54% | -35.30% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -86.67% | -86.67% | -77.29% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 56.05% | 56.05% | 143.66% | -- |
| Total Liabilities | -- | -64.77% | -64.77% | -34.29% | -- |
|
|
|||||
| Common Stock & APIC | -- | 1.61% | 1.61% | 11.38% | -- |
| Retained Earnings | -- | -4.74% | -4.74% | -13.84% | -- |
| Treasury Stock & Other | -- | -55.39% | -55.39% | -56.59% | -- |
| Total Common Equity | -18.32% | -9.19% | -9.19% | -13.82% | -25.01% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -18.32% | -9.19% | -9.19% | -13.82% | -25.01% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -18.32% | -9.19% | -9.19% | -13.82% | -25.01% |
|
|
|||||